For Research Use Only. MOTS-c is intended exclusively for in vitro and preclinical research. It is not approved for human use, is not a drug, and should never be administered to humans or to animals outside of an authorized research protocol.
Recent Peer-Reviewed Research Anchoring the Exercise-MOTS-c Axis
The functional case for MOTS-c as an exercise-induced mitochondrial-derived peptide rests on two converging lines of peer-reviewed work that should anchor any new preclinical study in the field.
The first is the Reynolds and colleagues 2021 Nature Communications paper, MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. The paper combines aged-rodent exercise interventions with chronic MOTS-c administration to demonstrate that the 16-amino-acid mitochondrial peptide is both up-regulated by exercise and capable of producing exercise-like adaptations when administered exogenously, including improved running endurance, preserved muscle mass, and shifts in skeletal-muscle transcriptional programs toward an oxidative phenotype. The reported active dose range in mouse models was 0.5 to 5 mg/kg by intraperitoneal injection, administered three times per week over 8 to 12 weeks. For investigators designing new MOTS-c exercise-mimetic studies, that paper sets the benchmark dosing, the standard endpoints (treadmill endurance, grip strength, body composition by NMR, and oxidative gene expression in gastrocnemius), and the comparator group structure that current preclinical work should reproduce.
The second is the 2023 review by Yang and colleagues, Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging, published in the Journal of Translational Medicine on the Springer Nature platform. This review collects the published literature on MOTS-c regulation of the folate-AICAR-AMPK axis, the nuclear translocation behavior of the peptide under metabolic stress, and the convergence with sirtuin and PGC-1 alpha signaling that links MOTS-c to the broader mitochondrial-biogenesis literature. For new investigators entering the field, the review provides a single reference work that frames the methodological landscape and identifies the principal open questions, including the unresolved mechanism by which MOTS-c gains access to the cytoplasm and the nucleus from its mitochondrial site of synthesis.
Together, these two references provide the empirical and conceptual anchors for current MOTS-c exercise research. Investigators publishing new work should cite both to ground their study design in the highest-quality available literature. For broader context on exercise-mimetic peptides and mitochondrial-derived signaling, the Cell Metabolism journal homepage and the Frontiers in Physiology aging hub collect adjacent reviews that situate MOTS-c within the larger landscape of mitochondrial-encoded regulatory peptides including humanin and the small humanin-like peptide family.
What Are Exercise Mimetics?
Exercise mimetics are research compounds that produce some of the cellular and metabolic effects of physical exercise without requiring the exercise itself. The exercise mimetic concept has motivated substantial research on compounds that target exercise-related signaling pathways, including AMPK, PGC-1 alpha, sirtuins, and various other components of the integrated exercise response.
The research interest in exercise mimetics reflects the broad biological effects of exercise on multiple organ systems and the recognition that these effects involve specific molecular signaling pathways that can potentially be activated through pharmacological means. Research compounds that activate exercise-related pathways provide tools for studying how the molecular components of exercise contribute to its broader biological effects.
The exercise mimetic research field has identified multiple compounds that produce some exercise-like effects in research models, although none replicate the full integrated effects of actual exercise. Each exercise mimetic research compound has its own specific profile and is appropriate for different research questions about exercise biology.
MOTS-c is one of the more conceptually interesting exercise mimetic research compounds because it is a mitochondrial-derived peptide that activates AMPK (one of the major exercise-responsive signaling pathways) and produces effects that overlap with exercise-induced changes in research models.
Exercise-Induced AMPK Activation
AMPK activation is one of the major molecular responses to exercise in skeletal muscle and other tissues. During exercise, the increased ATP consumption by muscle contraction leads to elevated AMP levels, which activates AMPK through its nucleotide-sensing mechanism. The AMPK activation then triggers downstream metabolic responses that help meet the energy demands of exercise.
The exercise-induced AMPK activation in skeletal muscle produces effects on glucose uptake (enhancing the muscle's ability to take up glucose for fuel), fatty acid oxidation (increasing the use of fat as fuel), mitochondrial biogenesis (over longer time scales, increasing the production of new mitochondria), and various other metabolic adaptations that contribute to the exercise response.
MOTS-c also activates AMPK through mechanisms discussed in our companion article on MOTS-c and metabolic homeostasis: AMPK pathway research. The convergence of MOTS-c effects with exercise-induced AMPK activation is one of the conceptual reasons for studying MOTS-c as an exercise mimetic research compound.
MOTS-c Effects on Exercise Capacity
Animal model studies of MOTS-c have characterized effects on exercise capacity in research animals. These studies typically use standardized exercise tests such as treadmill running protocols to measure how long research animals can sustain exercise before exhaustion or how much exercise capacity changes with various interventions.
The published findings on MOTS-c and exercise capacity in research animals generally support improvements in exercise performance with MOTS-c administration. The improvements include increased running distance, increased time to exhaustion, and various other measurements that reflect enhanced exercise capacity in research models.
The mechanism by which MOTS-c improves exercise capacity in research animals involves the AMPK pathway activation and downstream metabolic effects in skeletal muscle. The enhanced glucose uptake, increased fatty acid oxidation, and effects on mitochondrial biogenesis together contribute to improved muscle metabolism that supports enhanced exercise performance.
Skeletal muscle is the primary site of exercise effects in research animals, and MOTS-c effects on muscle metabolism are central to its exercise mimetic research profile. The peptide affects multiple aspects of muscle metabolism that overlap with the molecular effects of exercise.
Glucose uptake by muscle is one of the most studied aspects of muscle metabolism in exercise research. MOTS-c enhances glucose uptake in muscle through AMPK pathway activation, which produces effects similar to those of exercise on this endpoint.
Fatty acid oxidation by muscle is another major energy source during exercise, particularly during prolonged exercise where glycogen stores become depleted. MOTS-c enhances fatty acid oxidation in muscle through ACC inhibition (downstream of AMPK), which is consistent with exercise-induced enhancement of fat oxidation.
Mitochondrial biogenesis in muscle is a longer-term adaptation to exercise that increases the cellular machinery for energy production. MOTS-c effects on mitochondrial biogenesis through PGC-1 alpha activation overlap with the exercise-induced effects on this endpoint, providing a molecular basis for sustained metabolic improvements with chronic MOTS-c administration.
The combined effects on these multiple aspects of muscle metabolism produce a comprehensive metabolic profile that supports the exercise mimetic research applications of MOTS-c.
Comparison With Other Exercise Mimetics
MOTS-c is one of several compounds that have been studied as exercise mimetic research tools. Other exercise mimetic research compounds include AICAR (a small molecule AMPK activator), various PGC-1 alpha activators, sirtuin pathway research compounds, and the SLU-PP-332 ERR alpha agonist that has been studied as an exercise mimetic.
The comparison between MOTS-c and other exercise mimetic research compounds provides context for understanding the specific characteristics of the peptide. MOTS-c is a peptide rather than a small molecule, which gives it different pharmacological properties than the small molecule activators. The peptide nature also makes it functionally similar to natural endogenous regulators of exercise-related signaling.
The use of MOTS-c as an exercise mimetic research tool complements rather than replaces other exercise mimetic approaches. Each tool has its own strengths and appropriate research applications, and the combined use of multiple exercise mimetic research compounds in comparative research designs can provide more comprehensive characterization of exercise biology.
